CJC-1295 + Ipamorelin
CJC-1295 (no DAC) supplied with ipamorelin — the long-standing pairing in growth-hormone axis research, offered as a single pre-order line earlier on this site and now live.
Also known as: The GH stack
Research context
- Combines a GHRH analogue with a GH secretagogue.
- The most common growth-hormone pairing in the category.
- Was a pre-order line; now stocked as a standard SKU.
Full breakdown below: what it is • the category • common questions
CJC-1295 + Ipamorelin
from £20.40 per vial
| Strength | Price | |
|---|---|---|
| 10mg | £20.40bank £18.36 | Buy vial |
Bank transfer prices shown under each card price (10% off). Checkout runs on Stripe; bank orders confirm on clearance.
What this combination is
This is the two-compound presentation of CJC-1295 (no DAC) with ipamorelin. The pair is the standard secretagogue combination in GH-axis research: CJC-1295 is a GHRH-receptor agonist and ipamorelin is a ghrelin-receptor agonist, so the two act on different receptors that both drive growth hormone release. Research protocols use them together because the mechanisms are complementary rather than redundant.
Where the pair sits in the category
| Compound | Receptor / class | Character | Clinical documentation |
|---|---|---|---|
| CJC-1295 (no DAC) | GHRH analogue | Short-acting GHRH-receptor agonist | Preclinical + early-phase; no completed pivotal programme |
| Ipamorelin | Ghrelin-receptor agonist | Selective ghrelin-receptor agonist | Clinical studies; not approved as a product |
| GHRP-2 | Ghrelin-receptor agonist | Broader secretagogue, lighter literature | Preclinical + early-phase |
| Tesamorelin | GHRH analogue | Long-acting; the approved reference | Completed pivotal programme; US-approved product |
The practical takeaway: the CJC-1295 + ipamorelin pair covers both secretagogue pathways with the most commonly handled compounds on the shelf. If the research question needs the better-characterised GHRH-receptor reference instead, swap in tesamorelin.
How it is supplied and handled
Both compounds ship as lyophilised (freeze-dried) powder in sealed vials — the standard stable form for research peptides — and this page presents them as a single combined order. Once reconstituted with bacteriostatic water, both should be kept refrigerated and handled cold-chain; the reconstitution guide covers the volumes, arithmetic and storage handling for this class of compound. Every batch is supplied with a certificate of analysis (see the lab and COA policy), and batch-specific COAs can be requested via the contact page before ordering.
Ordering, payment and delivery
Pricing is per combined order — no minimum. Card checkout runs on Stripe; bank transfer is available at 10% off and confirms on clearance. UK dispatch is cold-chain, and delivery sets out the timelines and what to expect on arrival.
Common questions
Why combine CJC-1295 with ipamorelin?
Because they act on different receptors: CJC-1295 on the GHRH receptor, ipamorelin on the ghrelin receptor. Both pathways drive GH release, so research protocols use them together for complementary stimulation rather than stacking two molecules on the same receptor.
Is this one product or two?
It is the standard two-compound combination presented as a single order so the pair arrives together. You can also order each compound separately from its own page.
How is the pair documented?
Both compounds individually have a preclinical-to-early-phase evidence base; the combination itself is a research convention rather than a single approved product. Tesamorelin is the better-characterised single compound on the GHRH side if the research question needs that.
What are the prices and how do I pay?
The combined presentation is £20.40 by card, £18.36 by bank transfer. No minimum order; card checkout runs on Stripe and bank orders confirm on clearance.
Do I store them differently after reconstitution?
No — both are handled the same way: refrigerated, cold-chain, standard research-peptide handling. The reconstitution guide covers the specifics.
Is this a medicine?
As sold here both compounds are research chemicals. They are not licensed medicines in the UK, they are not for human or veterinary use, and nothing on this page is medical advice or a dosing recommendation.